News About: Pharm. Industry
While the listed pharmaceutical company with the highest debt ratio is ‘Isu Abxis,’ which is the one with the lowest?
Among listed pharmaceutical companies (including biopharmaceutical companies), companies with the highest and lowest debt ratios against equity capital are the rare disease treatment company, Isu Abxis, and the holdin...
The total amount of assets of listed pharmaceutical companies increased 6.4% up in the 1st quarter of the year
It is observed that the total amount of assets(capital + liability) of listed Korean pharmaceutical companies in the 1st quarter of the year increased 6.4% compared to the same quarter of the last year. Capitals and l...
The number of antibody prescriptions has constantly decreased while prescriptions for more than 6 products are increased by a small margin
It is known that antibody prescriptions have been continuously decreased for acute upper respiratory infection, such as flu. However, the decreasing trend on the number of pharmaceutical products per description has b...
GSK has acquired an approval for ‘Incruse Ellipta,’ reinforcing its COPD lineupGSK is in the heat of reinforcing its respiratory disease treatment pipeline. It is working on a long-acting anticholinergic(LAMA) drug this time.
The company has acquired a sa...
|
Why are the 5 companies missing from the innovation pharmaceutical company list?
In regards to the recertification of the 1st innovation pharmaceutical companies, various suspicion has been poured out. While 36 companies, such as Green Cross, Chong Kun Dang, Samjin Pharm, Ahngook Pharm and Hanmi P...
The pharmaceutical industry has kept a close watch on drug price of the Dong-A ST’s super antibacterial drug ‘Sivextro’As creation of a new global drug has been highly interested by the successful development of domestic pharmaceutical companies, the Dong-A ST’s new super antibacterial drug, ‘Si...
|
Enlargement of price limit benefited pharmaceutical stocks, increasing 20% in a favorable condition
Since the 15th of this month, enlargement of price limit from 15% to 30% has benefited stock price of pharmaceutical companies.
Although an opinion was raised that the spread of MERS might stop the uptrend of pharmac...
Pharmaceutical companies grasping the situation for the adoption of the ‘Wage Peak System’
While the government has selected the pharmaceutical field as a leading business type that will adopt the Wage Peak System among private companies, a number of top pharmaceutical companies have been hesitated to decid...
A private equity fund operator, ‘H&Q,’ takes over Ildong Pharmaceutical’s shares owned by Green Cross
H&Q Korea, a domestic private equity fund operator, will become the 2nd largest shareholder of Ildong Pharmaceutical as purchasing closely 25% of its shares owned by Green Cross, the former 2nd largest shareholder.
O...
What could be the reason why we need to pay attention to pharmaceutical holding companies with high potentials?
An analysis was conducted that pharmaceutical holding companies of the top pharmaceutical companies need to receive attention of the industry. This is because their affiliated companies have high potentials in growth....
